Homepage
Healthcare · Biotechnology · Luxembourg · Updated May 10, 11:33pm
$8.90
Price
$6.5M
Market Cap
52
Employees
0.37
Beta
Alejandro Antalich
CEO
Business Description
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Business History
Price Overview
Last updated: May 11, 2026 1:51pm (just now)$8.29
-0.61 (-6.85%)
Day Range
$7.81 – $8.74
52-Week Range
$3.08 – $157.05
50-Day MA
$8.70
200-Day MA
$13.28
Volume
21,067.00
Analyst Price Targets
Low
$45.00
Consensus
$45.00
High
$45.00
(1 analysts)
Share Structure
Outstanding
726,118.00
Float
517,027.00
Free Float
71.2%
Normal free float
— 71.2% of shares trade freely, ~28.8% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Small absolute float (0.5M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.03
Stock Price: $8.90
EPS (Diluted): -258.75
EPS (Diluted): -258.75
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
-0.62
Stock Price: $8.90
Total Equity: -$65.97M
Shares: 430,864
Total Equity: -$65.97M
Shares: 430,864
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-3.65
Market Cap: $6.46M
Total Debt: $246.88M
Cash: $767,919
EBITDA: -$69.01M
Total Debt: $246.88M
Cash: $767,919
EBITDA: -$69.01M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$286.8M
Market Cap: $6.46M
Total Debt: $246.88M
Cash: $767,919
Total Debt: $246.88M
Cash: $767,919
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
34.2%
Gross Profit: $114.01M
Revenue: $333.61M
Revenue: $333.61M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-3.1%
Operating Income: -$10.48M
Revenue: $333.61M
Revenue: $333.61M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-33.4%
Net Income: -$111.46M
Revenue: $333.61M
Revenue: $333.61M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
376.8%
Net Income: -$111.46M
Total Equity: -$65.97M
Total Equity: -$65.97M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-5.3%
Operating Income: -$10.48M
Tax Rate: -3.9%
Equity: -$65.97M
Total Debt: $246.88M
Cash: $767,919
Tax Rate: -3.9%
Equity: -$65.97M
Total Debt: $246.88M
Cash: $767,919
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
0.13
Current Assets: $31.19M
Current Liabilities: $236.05M
Current Liabilities: $236.05M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
-3.74
Short-Term Debt: $227.27M
Long-Term Debt: $19.61M
Total Debt: $246.88M
Total Equity: -$65.97M
Long-Term Debt: $19.61M
Total Debt: $246.88M
Total Equity: -$65.97M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$774.28
Revenue: $333.61M
Shares: 430,864
Shares: 430,864
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$-153.11
Total Equity: -$65.97M
Shares: 430,864
Shares: 430,864
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-69.87
Operating CF: -$24.45M
CapEx: -$5.65M
Shares: 430,864
CapEx: -$5.65M
Shares: 430,864
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $8.90
Stock Price: $8.90
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$111.46M
Net Income: -$111.46M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MLEC against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $905,049 | $5.6M | $333.6M |
| Cost of Revenue | $0 | $0 | $1.0M | $5.2M | $219.6M |
| Gross Profit | $0 | $0 | $-143,305 | $472,581 | $114.0M |
| Operating Expenses | $13,802 | $3.7M | $6.5M | $9.5M | $124.5M |
| Operating Income | $-13,800 | -$1.7M | -$6.7M | -$9.0M | -$10.5M |
| Net Income | $-13,802 | -$4.5M | -$51.8M | -$7.3M | -$111.5M |
| EBITDA | $-13,800 | -$3.7M | -$51.7M | -$6.2M | -$69.0M |
| EPS | $-0.01 | $-1.80 | $-22.50 | $-2.85 | $-258.75 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $337,603 | $1.1M | $2.5M | $5.4M | $767,919 |
| Total Current Assets | $581,697 | $1.1M | $5.3M | $13.7M | $31.2M |
| Total Assets | $138.6M | $5.7M | $24.1M | $34.8M | $204.7M |
| Current Liabilities | $861,854 | $4.1M | $12.6M | $8.2M | $236.1M |
| Long-Term Debt | $0 | $0 | $99,046 | $11.7M | $19.6M |
| Total Liabilities | $4.5M | $4.1M | $13.9M | $28.0M | $287.6M |
| Total Equity | $134.1M | $1.6M | $10.1M | $6.8M | -$66.0M |
| Retained Earnings | $-828,078 | -$6.8M | -$58.6M | -$65.9M | -$110.3M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-8,802 | -$1.9M | -$7.5M | -$9.3M | -$24.5M |
| Capital Expenditure | $0 | $0 | $-179,186 | $-158,283 | -$5.7M |
| Free Cash Flow | $-8,802 | -$1.9M | -$7.7M | -$9.5M | -$30.1M |
| Acquisitions (net) | $0 | $0 | -$1.9M | $0 | -$31.8M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $-305,000 | $-926,899 |
| Net Change in Cash | $5,689 | $131,024 | $1.4M | $2.9M | -$52.2M |
Analyst Estimates (Annual)
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$6.6M $6.6M – $6.6M
|
$8.6M $8.6M – $8.6M
|
$77.3M $77.3M – $77.3M
|
$130.8M $130.8M – $130.8M
|
| EBITDA |
$-274,759 $-274,759 – $-274,759
|
$-357,175 $-357,175 – $-357,175
|
-$3.2M -$3.2M – -$3.2M
|
-$5.4M -$5.4M – -$5.4M
|
| Net Income |
-$16.8M -$16.8M – -$16.8M
|
-$15.5M -$15.5M – -$15.5M
|
$2.6M $2.6M – $2.6M
|
$12.9M $12.9M – $12.9M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | +521.5% | +5,830.7% |
| Gross Profit Growth | — | — | +429.8% | +24,024.0% |
| Operating Income Growth | -12,339.6% | -287.6% | -35.9% | -15.9% |
| Net Income Growth | -32,698.9% | -1,044.0% | +85.9% | -1,424.3% |
| EBITDA Growth | -26,354.6% | -1,317.3% | +88.1% | -1,020.4% |
Insider Trading (Recent)
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2028-06-30 | Core Daniel Joaquin | 933.00 | $7.14 | $6,662 | |
| 2026-02-06 | Falottico Valeria Ines | 0.00 | $0.00 | $0 | |
| 2028-06-30 | Falottico Valeria Ines | 2,222.00 | $7.14 | $15,865 | |
| 2026-02-06 | Falottico Valeria Ines | 2,333.00 | $14.28 | $33,315 | |
| 2026-02-06 | Falottico Valeria Ines | 2,333.00 | $28.56 | $66,630 | |
| 2028-06-30 | Varela Lorenzo Romualdo Mariano | 933.00 | $7.14 | $6,662 | |
| 2028-06-30 | Diaz Dellavalle Paola Alexandra | 933.00 | $7.14 | $6,662 | |
| 2028-06-30 | Abelleyra Llodra Diego Juan | 933.00 | $7.14 | $6,662 | |
| 2028-06-30 | Antalich Raibar Alejandro Carlos | 3,333.00 | $7.14 | $23,798 | |
| 2026-02-06 | Antalich Raibar Alejandro Carlos | 6,667.00 | $14.28 | $95,205 | |
| 2026-02-06 | Antalich Raibar Alejandro Carlos | 6,666.00 | $28.56 | $190,381 | |
| 2028-06-30 | Leon Bentancor Oscar Alejandro | 933.00 | $7.14 | $6,662 | |
| 2025-06-16 | Montaron Estrada Gloria | 0.00 | $0.00 | $0 |
No community reviews yet for MLEC.
Be the first — export the analysis to your AI and contribute back.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27